Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2005
08/03/2005CN1212831C Pharmaceutical preparations
08/03/2005CN1212830C Delivery of solid drug compositions
08/03/2005CN1212826C Topically applied idebenone-containing agent with protective and regenerative effect
08/03/2005CN1212809C Subcutaneous implant
08/03/2005CN1212762C Mixture of fungicidal active compounds
08/03/2005CA2479385A1 Use of propargylamine as neuroprotective agent
08/02/2005US6925388 Heterocyclic nonnucleoside inhibitors of reverse transcriptase
08/02/2005US6924415 Identified as a target for therapeutic intervention due to its role in molecular events that lead to or contribute to cardiac hypertrophy and/or dilated cardiomyopathy
08/02/2005US6924398 Substituted tropolone compounds, oral care compositions containing the same and methods of using the same
08/02/2005US6924392 Ortho, meta-substituted bisaryl compounds, processes for their preparation, their use as medicaments, and pharmaceutical preparations comprising them
08/02/2005US6924391 Antiinflammatory agents; antitumor agent
08/02/2005US6924388 Bicyclic aromatic compounds and pharmaceutical/cosmetic compositions comprised thereof
08/02/2005US6924377 Etherifying mucochloric or mucobromic acid with an alcohol, alkylation, hydrogenation, dehydrochlorination or dehydrobromination, decyclization by reductive amination and carboxylation; 3-Aminomethyl-5-methyl-hexanoic acid
08/02/2005US6924376 Compounds, compositions and methods
08/02/2005US6924374 Modulators of dopamine neurotransmission
08/02/2005US6924356 Human protein HHEPU32
08/02/2005US6924314 Compounds for the treatment of metabolic disorders
08/02/2005US6924313 Substituted tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
08/02/2005US6924312 Taxol enhancer compounds
08/02/2005US6924311 Measuring blood concentration of high density lipoproteins;medical diagnosis of cardiovasular disorders
08/02/2005US6924310 Sulfur compounds such as N-[3,5-dichloro-4-(3-cyclopropylsulfamoyl-4-hydroxy-phenoxy)-phenyl]-malonamic acid, used as anoroexigenic, antiarrhythmia, hypotensive or antidiabetic agents; alopecia
08/02/2005US6924309 Modulation cystic fibrosis; antiinflammatory agents; antiallergens; rheumatic diseases; autoimmune diseases
08/02/2005US6924308 Therapeutic process for inhibiting NF-κB
08/02/2005US6924306 Potassium channel moderators
08/02/2005US6924305 Diazocine derivatives and their use as tryptase inhibitors
08/02/2005US6924303 Analgesic and anti-inflammatory compositions containing COX-2 inhibitors
08/02/2005US6924302 Nitrogen compounds such as 5-amino-3-[[4-(aminosulfonyl)phenyl]amino]-N-(2,6-difluorophenyl)-1H-1,2,4-triazole-1-carbothioamide, used as cyclin dependent and tyrosine kinase inhibitors, for prophylaxis of tumors
08/02/2005US6924301 Composition for treating or preventing arrhythmia
08/02/2005US6924300 Oxyiminoalkanoic acid derivatives
08/02/2005US6924299 Applying vasodilator to skin
08/02/2005US6924297 Naphathalene derivatives which bind to the EP4 receptor
08/02/2005US6924295 Hetereocyclic amines such as 3-(5-(2-(2-(4-methylphenyl)-5-methyloxazol-4-yl)ethoxy)-1,2,3,4-tetrahydroquinolin-1-yl)propanoic acid ethyl ester, used as peroxisome proliferator activated receptor modulators; hyperlipemia; diabetis;
08/02/2005US6924293 Sulfonamide and sulfamide substituted imidazoquinolines
08/02/2005US6924292 Nitrogen compounds such as 2-(methylsulfinyl) N [3-(3,4,8,9-tetrahydro-6-methoxy-3,3,8,8-tetramethylfuro[2,3-h]isoquinolin-1-yl)phenyl]acetamide, used as phosphodiesterase inhibitors; antidiabetics; antiinflammatory agents
08/02/2005US6924290 Antitumor agents; anticancer agents; sexual disorders; cardiovascular disorders
08/02/2005US6924289 Useful for treating or preventing a disorder or condition selected from hypertension, depression, anxiety, phobias, post trauma stress, sexual disfunction, eating disorder, obesity, Alzheimer's disease, Parkinson's disease etc.
08/02/2005US6924288 Enantiomerically pure opioid diarylmethylpiperzine and methods of using same
08/02/2005US6924287 Respiratory syncytial virus replication inhibitors
08/02/2005US6924286 Sulfur compounds such as phenylmethyl [2R-hydroxy-3-[(3-methylbutyl) (phenylsulfonyl)amino]-1S-(phenylmethyl)propyl]carbamate, used for prevention of viral diseases and replication
08/02/2005US6924284 PARP inhibitors
08/02/2005US6924283 4-thioxo-4,7-dihydro-thieno[2,3-b]pyridine-5-carbothioamides as antiviral agents
08/02/2005US6924282 5-(1,1-dioxido-1,2-thiazinan-2-yl)-n-(4-fluorobenzyl)-8-hydrox y-1,6-naphthyridine-7-carboxamide; preventing or treating hiv or aids
08/02/2005US6924281 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents
08/02/2005US6924280 Dipeptide derivatives
08/02/2005US6924279 An antibiotics for treating bacterial infections; bactericides
08/02/2005US6924278 Heterocyclic carboxy amines such as (2R)-1-[3,5-Bis(trifluoromethyl)benzoyl]-4-[4-((3S)-3-ethylmorpholino)-2-butynyl]-2-[(1H-indol-3-yl)methyl]piperazine, used as substance P and neurokinin antagonist for prophylaxis of diseases
08/02/2005US6924277 Central nervous system disorders; antidepressants; bipolar disorders; rhematic diseases
08/02/2005US6924276 Diacid-substituted heteroaryl derivatives as matrix metalloproteinase inhibitors
08/02/2005US6924275 Aminophenol derivatives and their use in cosmetics
08/02/2005US6924274 Or metabolizable precursors thereof, such as Delta 5-androstene-3b- acetoxy-7,17-dione, used to treat autoimmune disorders
08/02/2005US6924273 Chondroprotective/restorative compositions and methods of use thereof
08/02/2005US6924272 Medicinal composition for diabetic neuropathy
08/02/2005US6924271 Having immunomodulatory activity, for therapy and prophylaxis of diseases
08/02/2005US6924269 Prostaglandin inhibitors comprising boron compounds such as calcium mannitolo-borate, used for induction of apoptosis in cells and as analgesics
08/02/2005US6924151 Binding particles; for use in the treatment of blood disorders
08/02/2005US6924092 Testing prospective herbicides and parasiticides by incubating a substance with a monogalactodiacyl synthase or plastidal membrane products to select enzyme inhibitors; apicomplex parasites; antimalarial agents; coccidiosis;toxoplasmosis
08/02/2005US6923992 Active compounds of Bao-Ji-Wan for anti-diarrhea and relieving gastrointestinal symptoms
08/02/2005US6923990 comprises silver thiosulfate-tri-hydroxymethyl aminomethane complex; improved solvent miscibility; catheters
08/02/2005US6923988 Solid carrier includes a hydrophililc surfactant and a drug
08/02/2005US6923983 Transdermal delivery of hormones
08/02/2005US6923981 Fast dissolving orally consumable films
08/02/2005US6923967 comprises xanthophyll/astaxanthin esterified with fatty acid
08/02/2005US6923961 Chemically activated carboxypolysaccharides and methods for use to inhibit adhesion formation and promote hemostasis
08/02/2005US6923960 An antioxidant formulation comprises L-carnitine inner salt or a pharmacologically acceptable salt, acetyl L-carnitine inner salt or pharmacologically acceptable salt, lipoic acid alpha, coenzyme Q10, vitamin E and selenomethionine
08/02/2005US6923959 Method of pre-inducing a state of immune tolerance before organ transplantation
08/02/2005US6923654 Manikin and eye device apparatus, methods and articles of manufacture
08/02/2005CA2446939C Pyridylpyrimidine derivatives as effective compounds against prion diseases
08/02/2005CA2362339C Novel intermediates for the preparation of antihistaminic 4-diphenylmethyl/diphenylmethoxy piperidine derivatives
08/02/2005CA2362337C Novel intermediates for the preparation of antihistaminic 4-diphenylmethyl/diphenylmethoxy piperidine derivatives
08/02/2005CA2332538C Novel 4-phenylpiperidines for the treatment of pruritic dermatoses
08/02/2005CA2326528C Cholesterol sulfate compositions for artificial skin tanning
08/02/2005CA2325358C 7-¬(4'-trifluoromethyl-biphenyl-2-carbonyl)amino|-quinoline-3-carboxylic acid amides, and methods of inhibiting the secretion of apolipoprotein b
08/02/2005CA2321639C Bicyclo[2.2.1]heptanes and related compounds
08/02/2005CA2304821C Osteoblast-specific mitogens and drugs containing such compounds
08/02/2005CA2264094C Structured water for enhanced moisturization
08/02/2005CA2248968C Nasal administration of agents for treatment of delayed onset emesis
08/02/2005CA2243199C Novel 3,4-diaryl thiophenes and analogs thereof having use as antiinflammatory agents
08/02/2005CA2238190C Antifungal substances be-49385 and process for their production
08/02/2005CA2195957C Biocompatible hydrogel
08/02/2005CA2190837C Transdermal delivery of anti-epileptic drugs
08/02/2005CA2190087C Nitro compounds and their compositions having anti-inflammatory, analgesic and anti-thrombotic activities
08/02/2005CA2170020C Retroviral protease inhibiting compounds
08/02/2005CA2165824C Use of modafinil for the treatment of sleep apnea and ventilation problems of central origin
08/02/2005CA2154577C Novel inhibitors of adenosine monophosphate deaminase
08/02/2005CA2132537C Basic derivatives of glutamic acid and aspartic acid as gastrin or cholecystokinin antagonists
08/02/2005CA2119976C Pain management with lipsome-encapsulated analgesic drugs
08/02/2005CA2102960C Method of treating colon disturbances with pharmaceutical compositions containing imidazol-1-yl compounds
08/02/2005CA2091370C Tablets, granulates and pellets with a high active substance content for highly concentrated, solid dosage forms
07/2005
07/30/2005CA2495361A1 Treatment of psychoses with dibenzothiazepine antipsychotic
07/30/2005CA2494431A1 Pharmaceutical hard capsule containing inorganic substance
07/29/2005CA2455248A1 Oral administration of r-albuterol against obesity
07/28/2005WO2006080954A1 Ketolide derivatives as antibacterial agents
07/28/2005WO2005068632A1 EPITOPE/PEPTIDE RECOGNIZED BY HLA-A2402-RESTRICTED Ep-CAM-SPECIFIC CTL AND USE OF THE SAME
07/28/2005WO2005068624A1 Method of screening remedy for rheumatoid arthritis
07/28/2005WO2005068623A1 Method of screening remedy for rheumatoid arthritis
07/28/2005WO2005068501A1 Methods and compositions for modulating a steroid receptor
07/28/2005WO2005068490A1 Inclusion complexes of perindopril
07/28/2005WO2005068487A2 Processes for the preparation of rocuronium bromide and intermediates thereof
07/28/2005WO2005068485A1 Pharmaceutical composition comprising flavonoid compounds isolated from the extract of sedum sarmentosum bunge for preventing and treating hypertension
07/28/2005WO2005068473A1 Bicyclic pyrazolo-fused compounds as protein kinase modulators
1 ... 4596 4597 4598 4599 4600 4601 4602 4603 4604 4605 4606 4607 4608 4609 4610 4611 4612 4613 4614 4615 4616 ... 7860